Devolution review group's first meeting
The first meeting of the Royal Pharmaceutical Society's devolution review group was due to take place on 6 August at the Society's Scottish Department in Edinburgh.
The review group, chaired by Lord Fraser of Carmyllie, is to evaluate
the function, structure and ways of working of the Society to ensure
that it can fully meet the challenges and opportunities presented by
devolution.
Issues covered by the review will include: a framework for the devolution
of functions within a Britain-wide organisation; requirements for governance
and accountability; the scope, role of and the structures and processes
for policy-making; and the structure and function of the Scottish Executive
and Welsh Executive and their relationships with the Council and the
Society’s directorates.
Ann Lewis, Secretary and Registrar, said: “The Society has already
had good deal of success with the devolved administrations to ensure
that pharmacy’s voice is heard in both Scotland and Wales. I am
looking forward to this first meeting of the review group, which will
help us plan for the long-term future. The August meeting will agree
the terms of reference and ways of working of the group and consider
how best to consult with members in both Scotland and Wales.”
The review has also been welcomed by Angela Timoney, chairman of the
Scottish Executive, and Mair Davies, chairman of the Welsh Executive.
The review group includes the current and former chairmen of the Scottish
and Welsh Executives, members of Council, the Secretary and Registrar
and Paul Jervis, a constitutional specialist with expertise in devolution.
The group will complete its report in late 2004. It will form part of
the Society’s strategy and business planning programme.
|
The
Pharmaceutical Journal